Eric Ankerud serves as Executive at OCULAR THERAPEUTIX, INC, where they oversee executive responsibilities. Since joining the company, Eric Ankerud has executed 1 insider transactions totaling $13.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 30, 2014 involved purchasing 1,000 shares valued at $13.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 30, 2014 | OCUL | $13.0K | Purchase | 1,000 | $13.00 | Discretionary |
Eric Ankerud currently holds 78,651 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Ankerud has been a net buyer of OCUL stock. They have purchased $13.0K and sold $0 worth of shares.
Eric Ankerud's most recent insider trade was on Jul 30, 2014, when they purchased 1,000 shares at $13.00 per share.
Get notified when new Form 4 filings are submitted